Skip to content
2000
Volume 21, Issue 9
  • ISSN: 1573-4072
  • E-ISSN: 1875-6646

Abstract

, called as Alkanet, is considered as a perennial plant (family: Boraginaceae). The plant is well-known for its large quantity of naphthoquinone enantiomers, specifically Alkannin and Shikonin (A/S). These compounds offer various pharmaceutical applications and find use in cosmetics, food supplements, and natural dyes. A search was conducted on the online databases Scopus, ScienceDirect, PubMed, Web of Science, and Google Scholar using the following keywords including traditional applications, phytochemical compositions, alkannin, shikonin, endangered species, wound healing, ulcer, and toxicity about . Shikonin known for a coloured pigment that has been isolated from has several potential effects as an anti-inflammatory, anticancer agent and in the management of wound healing. However, several obstacles prevent them from reaching their full potential. Sustainable production is a significant obstacle; relying on plant sources raises worries about supply and environmental impact, which necessitates the use of alternate technologies such as plant tissue culture or microbial biosynthesis. Also, possible side effects and toxicity need to be fully studied to make sure they are safe for people to use. The current manuscript describes the isolation, biosynthesis, patents filed, clinical trials, toxicity studies, and various novel formulations containing A/S.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cbc/10.2174/0115734072307327241023182640
2025-10-30
2025-10-21

  • From This Site

    /content/journals/cbc/10.2174/0115734072307327241023182640
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Sabih OzerM. SarikurkcuC. TepeB. CanS. Essential oil composition and antioxidant activities of alkanet (Alkanna tinctoria subsp. tinctoria).Food Sci. Biotechnol.20101951177118310.1007/s10068‑010‑0168‑x
     [Google Scholar]
  2. AkcinO.E. KandemurN. CansaranA. Morphological and anatomical study on endemic Alkanna haussknechtii Bornm. (Boraginaceae), critically endangered in Turkey.Turk. J. Bot.200428591598
     [Google Scholar]
  3. AlwahibiM.S. PerveenK. Chemical analysis by GC-MS and in vitro antibacterial activity of Alkanna tinctoria extracts against skin infection causing bacteria.Biomed. Res. (Aligarh)2017281879467949
     [Google Scholar]
  4. MoustafaA.R.A. Distribution behaviour and seed germination of Alkanna orientalis Growing in Saint Catherine protectorate.Pak. J. Biol. Sci.20025442743310.3923/pjbs.2002.427.433
     [Google Scholar]
  5. RoederE. Medicinal plants in Europe containing pyrrolizidine alkaloids.Pharmazie19955028398 7700976
     [Google Scholar]
  6. LloydG.B. McCownB.H. Commercially feasible micropropagation of mountain laurel (Kalmia latifolia) by use of shoot-tip culture. Int Plant Propag.Società.198030421437
     [Google Scholar]
  7. BissetN.G. Herbal Drugs and Phytopharrnaceuticals: A Handbook for Practice on a Scientific Basis.Int. J. Pharmacogn.199735172
     [Google Scholar]
  8. Abdel-GelilO.E. AtwaN.A. MoustafaA.R. MansourS.R. Alkanna species: A promising herbal medicine and its uses.J. Food Sci. Nutr. Res.201924309315
     [Google Scholar]
  9. CartabiaA. SarropoulouV. GrigoriadouK. MaloupaE. DeclerckS. In vitro propagation of Alkanna tinctoria Tausch.: a medicinal plant of the Boraginaceae family with high pharmaceutical value.Ind. Crops Prod.202218211486010.1016/j.indcrop.2022.114860
     [Google Scholar]
  10. DasA. BiswasS. SatyaprakashK. BhattacharyaD. NandaP.K. PatraG. MoirangthemS. NathS. DharP. VermaA.K. BiswasO. TardiN.I. BhuniaA.K. DasA.K. Ratanjot (Alkanna tinctoria L.) Root Extract, Rich in Antioxidants, Exhibits Strong Antimicrobial Activity against Foodborne Pathogens and Is a Potential Food Preservative.Foods20241314225410.3390/foods13142254 39063340
     [Google Scholar]
  11. GutierrezS. Ang-LeeM.K. WalkerD.J. ZacnyJ.P. Assessing subjective and psychomotor effects of the herbal medication valerian in healthy volunteers.Pharmacol. Biochem. Behav.2004781576410.1016/j.pbb.2004.02.011 15159134
     [Google Scholar]
  12. MustafaG. ArifR. AttaA. SharifS. JamilA. Bioactive compounds from medicinal plants and their importance in drug discovery in Pakistan.Matrix Science Pharma201711172610.26480/msp.01.2017.17.26
     [Google Scholar]
  13. MishraB.B. TiwariV.K. Natural products: An evolving role in future drug discovery.Eur. J. Med. Chem.201146104769480710.1016/j.ejmech.2011.07.057 21889825
     [Google Scholar]
  14. GoraneA. NaikA. NikamT. TripathiT. AdeA. GCMS analysis of phytocomponents of C. papaya variety red lady.J. Pharmacogn. Phytochem.201872553555
     [Google Scholar]
  15. AssimopouloA.N. Analysis of alkannin derivatives from Alkanna species by high‐performance liquid chromatography/photodiode array/mass spectrometry.Biomed. Chromatogr.2006201213591374 17080496
     [Google Scholar]
  16. ÖzcanT. Analysis of the total oil and fatty acid composition of seeds of some Boraginaceae taxa from Turkey.Plant Syst. Evol.20082743-414315310.1007/s00606‑008‑0039‑6
     [Google Scholar]
  17. ErdemogluN. KusmenogluS. VuralM. γ‐Linolenic acid content and fatty acid composition of Boraginaceae seed oils.Eur. J. Lipid Sci. Technol.2004106316016410.1002/ejlt.200300910
     [Google Scholar]
  18. ChojkierM. Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids.J. Hepatol.200339343744610.1016/S0168‑8278(03)00231‑9 12927933
     [Google Scholar]
  19. KhanU.A. RahmanH. QasimM. HussainA. AzizllahA. MuradW. KhanZ. AneesM. AdnanM. Alkanna tinctoria leaves extracts: a prospective remedy against multidrug resistant human pathogenic bacteria.BMC Complement. Altern. Med.201515112710.1186/s12906‑015‑0646‑z 25902854
     [Google Scholar]
  20. EsfahaniH.R.M. SalimikiaI. YazdinezhadA.R. GolfakhrabadiF. In vitro antioxidant and free radical scavenging activity of four Alkanna species growing in Iran.Pharmacognosy Res.20157110010410.4103/0974‑8490.147218 25598642
     [Google Scholar]
  21. KhanR.A. AwanA.K. AhmedM. AlkreathyH. GulA. KhanA.M. MahmoodA. KhanA. Ul HaqM.N. AlzahraniK.S. In-vitro Antioxidant, Antidiabetic Activities and Phytotoxic Profile of Alkanna tinctoria (Boraginaceae).J. Pharm. Res. Int.20223414364210.9734/jpri/2022/v34i14B35681
     [Google Scholar]
  22. YangJ. LiJ. YangL. GuoR. Alkannin reverses lipopolysaccharides-induced inflammatory responses by suppressing mitogen-activated protein kinase and nuclear factor kappa-B signalling.Bioengineered2022137-12149361494610.1080/21655979.2023.2184455 37105673
     [Google Scholar]
  23. AssimopoulouA. BoskouD. PapageorgiouV.P. Antioxidant activities of alkannin, shikonin and Alkanna tinctoria root extracts in oil substrates.Food Chem.200487343343810.1016/j.foodchem.2003.12.017
     [Google Scholar]
  24. NayakU. BarikE. PatraB.K. BeheraS.R. PandeyM. BhattaK. TabishA. BeheraP. Alkanna tinctoria Derived Phytochemicals against Staphylococcus aureus Causing Eczema.J. Pharm. Res. Int.202032910210510.9734/jpri/2020/v32i930536
     [Google Scholar]
  25. Merci̇mek TakciH.A. TurkmenF.U. AnlasF.C. Ustun AlkanF. BakirhanP. Demi̇rC. SekerogluN. Antimicrobial activity and cytotoxicity of alkanna tinctoria (l.) tausch root extracts.Karadeniz Fen Bilimleri Dergisi20199117618510.31466/kfbd.566276
     [Google Scholar]
  26. JaloobA.A. Antibacterial activity of an aqueous extracts of Alkanna tinctoria roots against drug resistant aerobic pathogenic bacteria isolated from patients with burns infections.Russian Open Medical Journal.201871104
     [Google Scholar]
  27. SaghafiM.M. BehiF. LotfaliE. VosooghM. KreftS. FattahiM. In vitro and In vivo Antifungal Activity of Alkanna tinctoria against Trichophyton rubrun and Trichophyton mentagrophytes.Indian J. Pharm. Sci.20211733340
     [Google Scholar]
  28. RaniV.B.C.R. GS M, Deshpande S, Venkatesan J, Appana Dalavi P, Prabhu A. Cytotoxic and apoptotic efficacy of Alkanna tinctoria on glioma cells.Nat. Prod. Res.2023372238733877
     [Google Scholar]
  29. GuemmazT. ArrarL. BaghianiA. Total phenolic contents and antioxidant properties of Algerian Alkanna tinctoria aerial part extracts.J. Drug Deliv. Ther.2020105394410.22270/jddt.v10i5.4349
     [Google Scholar]
  30. YangX. FanW. HuangR. LiuG. β-acetoxyisovaleryl alkannin (AAN-II) from Alkanna tinctoria promotes the healing of pressure-induced venous ulcers in a rabbit model through the activation of TGF-β/Smad3 signaling.Cell. Mol. Biol. Lett.20212613510.1186/s11658‑021‑00278‑5 34332546
     [Google Scholar]
  31. FarhanA. AlsuwaytB. AlanaziF. YaseenA. AshourM.A. Evaluation and HPLC characterisation of a new herbal ointment for the treatment of full-thickness burns in rats.J. Taibah Univ. Med. Sci.202116215216110.1016/j.jtumed.2020.10.023 33897320
     [Google Scholar]
  32. AdeelS. KiranS. AlamM. FarooqT. AminN. GulzarT. Alkanna tinctoria-based sustainable alkanin natural colorant for eco-dyeing of wool.Environ. Sci. Pollut. Res. Int.20223010270732708010.1007/s11356‑022‑23806‑y 36374386
     [Google Scholar]
  33. KolettiA.E. KontogiannopoulosK.N. GardikisK. LetsiouS. PapageorgiouV.P. AssimopoulouA.N. Liposomal formulations of Alkanna tinctoria root extracts for dermal applications.Planta Med.202187151287
     [Google Scholar]
  34. LiW. YangX. YanS. WangL. LiuG.I. Effect of zizhu ointment on expressopn of Wnt signaling pathway in patient with diabetic foot ulcer.Acta Chin Med.2019344859862
     [Google Scholar]
  35. DengS. MayB.H. ZhangA.L. LuC. XueC.C.L. Topical herbal formulae in the management of psoriasis: systematic review with meta-analysis of clinical studies and investigation of the pharmacological actions of the main herbs.Phytother. Res.201428448049710.1002/ptr.5028 23817996
     [Google Scholar]
  36. WuZ. WuL. LiL. TashiroS. OnoderaS. IkejimaT. p53-mediated cell cycle arrest and apoptosis induced by shikonin via a caspase-9-dependent mechanism in human malignant melanoma A375-S2 cells.J. Pharmacol. Sci.200494216617610.1254/jphs.94.166 14978355
     [Google Scholar]
  37. KimS.H. KangI.C. YoonT.J. ParkY.M. KangK.S. SongG.Y. AhnB.Z. Antitumor activities of a newly synthesized shikonin derivative, 2-hyim-DMNQ-S-33.Cancer Lett.2001172217117510.1016/S0304‑3835(01)00665‑6 11566493
     [Google Scholar]
  38. ChangI.C. HuangY.J. ChiangT.I. YehC.W. HsuL.S. Shikonin induces apoptosis through reactive oxygen species/extracellular signal-regulated kinase pathway in osteosarcoma cells.Biol. Pharm. Bull.201033581682410.1248/bpb.33.816 20460760
     [Google Scholar]
  39. ValipourM. Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.Eur. J. Med. Chem.202223511431410.1016/j.ejmech.2022.114314 35367708
     [Google Scholar]
  40. MasudaY. ShimaG. AiuchiT. HorieM. HoriK. NakajoS. KajimotoS. Shibayama-ImazuT. NakayaK. Involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by β-hydroxyisovalerylshikonin.J. Biol. Chem.200427941425034251510.1074/jbc.M404256200 15292218
     [Google Scholar]
  41. ChengH.M. QiuY.K. WuZ. ZhaoY.F. DNA damage induced by shikonin in the presence of Cu(II) ions: potential mechanism of its activity to apoptotic cell death.J. Asian Nat. Prod. Res.2011131121910.1080/10286020.2010.537262 21253945
     [Google Scholar]
  42. MaoX. Rong YuC. Hua Li, W.; Xin Li, W. Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells.Cell Res.200818887988810.1038/cr.2008.86 18663379
     [Google Scholar]
  43. RuanM. JiT. YangW. DuanW. ZhouX. HeJ. ZhouJ. ChenW. ZhangC. Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca‐8113 cell lines by shikonin was partly through the inactivation of NF‐κB pathway.Phytother. Res.200822340741510.1002/ptr.2340
     [Google Scholar]
  44. KomiY. SuzukiY. ShimamuraM. KajimotoS. NakajoS. MasudaM. ShibuyaM. ItabeH. ShimokadoK. OettgenP. NakayaK. KojimaS. Mechanism of inhibition of tumor angiogenesis by β‐hydroxyisovalerylshikonin.Cancer Sci.2009100226927710.1111/j.1349‑7006.2008.01049.x 19200258
     [Google Scholar]
  45. YangH. ZhouP. HuangH. ChenD. MaN. CuiQ.C. ShenS. DongW. ZhangX. LianW. WangX. DouQ.P. LiuJ. Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo.Int. J. Cancer2009124102450245910.1002/ijc.24195 19165859
     [Google Scholar]
  46. BoulosJ.C. RahamaM. HegazyM.E.F. EfferthT. Shikonin derivatives for cancer prevention and therapy.Cancer Lett.201945924826710.1016/j.canlet.2019.04.033 31132429
     [Google Scholar]
  47. XuanY. HuX. Naturally-occurring shikonin analogues – A class of necroptotic inducers that circumvent cancer drug resistance.Cancer Lett.2009274223324210.1016/j.canlet.2008.09.029 19027226
     [Google Scholar]
  48. MinR. ZunZ. MinY. WenhuD. WenjunY. ChenpingZ. Shikonin inhibits tumor invasion via down‐regulation of NF‐κB‐mediated MMP‐9 expression in human ACC‐M cells.Oral Dis.201117436236910.1111/j.1601‑0825.2010.01758.x 21029262
     [Google Scholar]
  49. ChenX. YangL. ZhangN. TurpinJ.A. BuckheitR.W. OsterlingC. OppenheimJ.J. HowardO.M.Z. Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1.Antimicrob. Agents Chemother.20034792810281610.1128/AAC.47.9.2810‑2816.2003 12936978
     [Google Scholar]
  50. RennebergR. Biotechnology for Beginners.3rd edAcademic Press202324129010.1016/B978‑0‑323‑85569‑3.00017‑9
     [Google Scholar]
  51. Al-MussawiA.A. Isolation and identification of shikonin from Arnebia Decumbens L. and its antibacterial activity.J. Appl. Sci. Res.20106914521456
     [Google Scholar]
  52. AzumaH. LiJ. YoudaR. SuzukiT. MiyamotoK. TaniguchiT. NagasakiT. Improved isolation procedure for shikonin from the root of the Chinese medicinal plant Lithospermum erythrorhizon and its solubilization with cyclodextrins.J. Appl. Res. Med. Aromat. Plants201632586310.1016/j.jarmap.2016.01.002
     [Google Scholar]
  53. HuangX.Y. FuH.L. TangH.Q. YinZ.Q. ZhangW. ShuG. YinL.Z. ZhaoL. YanX.R. LinJ.C. Optimization extraction of shikonin using ultrasound-assisted response surface methodology and antibacterial studies.Evid. Based Complement. Alternat. Med.202020201120861710.1155/2020/1208617 32802111
     [Google Scholar]
  54. TsermentseliS.K. ManesiotisP. AssimopoulouA.N. PapageorgiouV.P. Molecularly imprinted polymers for the isolation of bioactive naphthoquinones from plant extracts.J. Chromatogr. A20131315152010.1016/j.chroma.2013.09.044 24075017
     [Google Scholar]
  55. NewmanJ.D. ChappellJ. Isoprenoid biosynthesis in plants: carbon partitioning within the cytoplasmic pathway.Crit. Rev. Biochem. Mol. Biol.19993429510610.1080/10409239991209228 10333387
     [Google Scholar]
  56. LichtenthalerH.K. RohmerM. SchwenderJ. Two independent biochemical pathways for isopentenyl diphosphate and isoprenoid biosynthesis in higher plants.Physiol. Plant.1997101364365210.1111/j.1399‑3054.1997.tb01049.x
     [Google Scholar]
  57. EisenreichW. RohdichF. BacherA. Deoxyxylulose phosphate pathway to terpenoids.Trends Plant Sci.200162788410.1016/S1360‑1385(00)01812‑4 11173292
     [Google Scholar]
  58. Rodríguez-ConcepciónM. BoronatA. Elucidation of the methylerythritol phosphate pathway for isoprenoid biosynthesis in bacteria and plastids. A metabolic milestone achieved through genomics.Plant Physiol.200213031079108910.1104/pp.007138 12427975
     [Google Scholar]
  59. HeideL. NishiokaN. FukuiH. TabataM. Enzymatic regulation of shikonin biosynthesis in Lithospermum erythrorhizon cell cultures.Phytochemistry19892871873187710.1016/S0031‑9422(00)97877‑4
     [Google Scholar]
  60. YazakiK. KunihisaM. FujisakiT. SatoF. Geranyl diphosphate:4-hydroxybenzoate geranyltransferase from Lithospermum erythrorhizon. Cloning and characterization of a ket enzyme in shikonin biosynthesis.J. Biol. Chem.200227786240624610.1074/jbc.M106387200 11744717
     [Google Scholar]
  61. ShedoevaA. LeavesleyD. UptonZ. FanC. Wound healing and the use of medicinal plants.Evid. Based Complement. Alternat. Med.2019201913010.1155/2019/2684108 31662773
     [Google Scholar]
  62. YinS.Y. PengA.P. HuangL.T. WangY.T. LanC.W. YangN.S. The phytochemical shikonin stimulates Epithelial-Mesenchymal Transition (EMT) in skin wound healing.Evid. Based Complement. Alternat. Med.20132013262796
     [Google Scholar]
  63. ParkJ.Y. KwakJ.H. KangK.S. JungE.B. LeeD.S. LeeS. JungY. KimK.H. HwangG.S. LeeH.L. YamabeN. KimS.N. Wound healing effects of deoxyshikonin isolated from Jawoongo: In vitro and in vivo studies.J. Ethnopharmacol.201719912813710.1016/j.jep.2016.10.031 27725239
     [Google Scholar]
  64. OrdoudiS.A. TsermentseliS.K. NenadisN. AssimopoulouA.N. TsimidouM.Z. PapageorgiouV.P. Structure-radical scavenging activity relationship of alkannin/shikonin derivatives.Food Chem.2011124117117610.1016/j.foodchem.2010.06.004
     [Google Scholar]
  65. AndújarI. RíosJ. GinerR. RecioM. Pharmacological properties of shikonin - a review of literature since 2002.Planta Med.201379181685169710.1055/s‑0033‑1350934 24155261
     [Google Scholar]
  66. OkurM.E. KarantasI.D. ŞenyiğitZ. Üstündağ OkurN. SiafakaP.I. Recent trends on wound management: New therapeutic choices based on polymeric carriers.Asian J. Pharm. Sci.202015666168410.1016/j.ajps.2019.11.008 33363624
     [Google Scholar]
  67. ChenChen. T.; Yu, S.C.; Hsu, C.M.; Tsai, F.J.; Tsai, Y. A water-based topical Chinese traditional medicine (Zicao) for wound healing developed using 2-hydroxypropyl-β-cyclodextrin.Colloids Surf. B Biointerfaces2018165677310.1016/j.colsurfb.2018.02.013 29454166
     [Google Scholar]
  68. NindawatS. AgrawalV. Fabrication of silver nanoparticles using Arnebia hispidissima (Lehm.) A. DC. root extract and unravelling their potential biomedical applications.Artif. Cells Nanomed. Biotechnol.201947116618010.1080/21691401.2018.1548469 30714404
     [Google Scholar]
  69. GargS. ChandraA. MazumderA. MazumderR. Green synthesis of silver nanoparticles using Arnebia nobilis root extract and wound healing potential of its hydrogel.Asian J. Pharm.2014829510.4103/0973‑8398.134925
     [Google Scholar]
  70. MoradiF. SedaghatS. MoradiO. Arab SalmanabadiS. Review on green nano-biosynthesis of silver nanoparticles and their biological activities: with an emphasis on medicinal plants.Inorganic and Nano-Metal Chemistry202151113314210.1080/24701556.2020.1769662
     [Google Scholar]
  71. BediN. KaurK. SinghA. SharmaH. PunjS. Formulation strategies and therapeutic applications of shikonin and related derivatives.Recent Adv. Drug Deliv. Formul.2022161556710.2174/2667387816666220302112201 35236278
     [Google Scholar]
  72. BhullarS.K. ButtarH.S. Perspectives on nanofiber dressings for the localized delivery of botanical remedies in wound healing.AIMS Mater. Sci.20174210.3934/matersci.2017.2.370
     [Google Scholar]
  73. YangB.Y. HuC.H. HuangW.C. HoC.Y. YaoC.H. HuangC.H. Effects of bilayer nanofibrous scaffolds containing curcumin/lithospermi radix extract on wound healing in streptozotocin-induced diabetic rats.Polymers (Basel)20191111174510.3390/polym11111745 31653001
     [Google Scholar]
  74. HanJ. ChenT.X. Branford-WhiteC.J. ZhuL.M. Electrospun shikonin-loaded PCL/PTMC composite fiber mats with potential biomedical applications.Int. J. Pharm.20093821-221522110.1016/j.ijpharm.2009.07.027 19660536
     [Google Scholar]
  75. PapageorgiouV. AssimopoulouA. SamanidouV. PapadoyannisI. Recent advances in chemistry, biology and biotechnology of alkannins and shikonins.Curr. Org. Chem.200610162123214210.2174/138527206778742704
     [Google Scholar]
  76. LiJ. LiS. LiH. GuoX. GuoD. YangY. WangX. ZhangC. ShanZ. XiaX. ShiC. Antibiofilm activity of shikonin against Listeria monocytogenes and inhibition of key virulence factors.Food Control202112010755810.1016/j.foodcont.2020.107558
     [Google Scholar]
  77. LeeY.S. LeeD.Y. KimY.B. LeeS.W. ChaS.W. ParkH.W. KimG.S. KwonD.Y. LeeM.H. HanS.H. The mechanism underlying the antibacterial activity of shikonin against methicillin-resistant Staphylococcus aureus.Evid. Based Complement. Alternat. Med.20152015520578
     [Google Scholar]
  78. GajdácsM. The continuing threat of methicillin-resistant Staphylococcus aureus.Antibiotics 2019825210.3390/antibiotics8020052 31052511
     [Google Scholar]
  79. WangF. Method of treatment of virus infections using shikonin compounds.US Patent 78976402011
  80. HanW. LiL. QiuS. LuQ. PanQ. GuY. LuoJ. HuX. Shikonin circumvents cancer drug resistance by induction of a necroptotic death.Mol. Cancer Ther.2007651641164910.1158/1535‑7163.MCT‑06‑0511 17513612
     [Google Scholar]
  81. MatthaiouE.I. BararJ. SandaltzopoulosR. LiC. CoukosG. OmidiY. Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer.Int. J. Nanomedicine2014918551870 24790428
     [Google Scholar]
  82. EskandaniM. NazemiyehH. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: Formulation, physicochemical characterization and geno/cytotoxicity evaluation.Eur. J. Pharm. Sci.201459495710.1016/j.ejps.2014.04.009 24768857
     [Google Scholar]
  83. LiH. TongY. BaiL. YeL. ZhongL. DuanX. ZhuY. Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma. Int. J. Biol. Macromol.,2018107(Pt A), 204-21110.1016/j.ijbiomac.2017.08.155 28863897
     [Google Scholar]
  84. EndlyD.C. MillerR.A. Oily skin: a review of treatment options.J. Clin. Aesthet. Dermatol.20171084955 28979664
     [Google Scholar]
  85. LiJ. ZhaoM. XuY. HuX. DaiY. WangD. Methods for procedures related to the electrophysiology of the heart.US Patent 55290671995
     [Google Scholar]
  86. YonganY. YuangangW. HuiZ. Hyun-wooK. JiwenY. Composition containing alkannin and lemon grass essential oil.Patent CN105582383A2016
     [Google Scholar]
  87. TaranL.M. BasharovA.Y. SlobodenyukE.V. BulgakovV.P. StrelnikovaN.V. Polymer film with naphthoquinone complex of biologically active substances of red-rooted gromwell.Patent RU2595880C12015
     [Google Scholar]
  88. YuW. HaitaoX. BinW. YanG. A kind of treat the herbal mixture nanometer emulsifiable paste that skin is chapped from the cold.Patent CN106138083A2016
     [Google Scholar]
  89. GeX. Preoperative nursing gel for anorectal surgery and preparation method of gel.Patent CN1059633672016
     [Google Scholar]
  90. FeixinW. Medicine containing alkannin compound as active component.Patent CN101288665A2003
     [Google Scholar]
  91. WangF. Pharmaceuticals comprising shikonins as active constituent.US Patent US20050222258A12005
     [Google Scholar]
  92. XunH. JianpingF. Use of alkannin in preparing medicine for treating tumor disease.Patent CN1579378A2004
  93. Microcapsule containing alkannin and preparation method and application thereof.Patent CN108042511B2017
  94. JinglinL. ShufenL. ZhuyingS. ChuanxinL. ShiquanP. Institute of Processing and Utilization of Agricultural Byproducts Liaoning Academy of Agricultural Sciences. Process for preparing natural alkannin.Patent CN1206726A1997
     [Google Scholar]
  95. LiminZ. JieH. Alkanna tinctoria drug loading nano fiber, preparation and application thereof.Patent CN101358383A2008
     [Google Scholar]
  96. YonghuaY. HongmeiX. JinliangQ. XiaomingW. RongwuY. HongchangL. Haoriqinbatu, .; Jingjing, Z.; Wenyao, K. Preparation method and application of liposomes of shikonin and derivatives or modifiers thereof.patent CN102091037A2011
     [Google Scholar]
  97. HongyingX. Skin-moistening cream containing alkannin.2012Patent CN 103301052A), 2012
     [Google Scholar]
  98. HongyingX. Making method of alkannin-containing emollient cream.Patent CN 103301053A2012
     [Google Scholar]
  99. XiaojuanP. FangW. XuemeiT. Subdued CongW. JianZ. The extracting method of Shikonin.Patent CN103373913B2012
     [Google Scholar]
  100. PingS. JieruF. QingZ. BenN. A kind of preparation method of moisturizing lipstick containing shikonin liposome.Patent CN108578262B2018
     [Google Scholar]
  101. KangL. ZhijunW. Alkannin bacteriostatic lipstick. Patent CN1116923A1995
     [Google Scholar]
  102. FangC. ShoukangL. Alkanna tinctoria haematochrome health-care beautifying cosmetics and its preparing method.Patent CN1220139A1998
     [Google Scholar]
  103. KeL. JunfengL. HuayingF. MengS. CuicuiY. LixinY. HaiqingZ. YumeiD. LijuanL. Gromwell extract for treating rheumatoid arthritis, and soft capsules thereof.Patent CN102198124B2010
     [Google Scholar]
  104. GanjunY. QiulingS. YuX. WeiweiP. Shikonin amino deoxy glycosides and application thereof in preparation of antitumor medicines.Patent CN102424696A2011
     [Google Scholar]
  105. DaofengC. JiahongJ. GuoxiongL. Shikonin tetramer compound and purpose thereof in pharmacy.Patent CN103086864A2011
     [Google Scholar]
  106. LiminZ. JieH. Branford-WhiteC. Shikonin PCL/PTMC composite nano fiber and preparation and application.Patent CN101591818A2009
     [Google Scholar]
  107. YunhuiX. HongfeiZ. ZhaofangD. YingZ. Monocarboxyl chitosan/alkannin composite nano-particles and preparation method thereof.Patent CN110384684B2019
     [Google Scholar]
  108. KurakakeJ. KenzoI. Composition containing shikonin and/or its derivative.Patent JPS6058909A1983
     [Google Scholar]
  109. WangF. Pharmaceuticals comprising shikonins as active constituent.Patent EP1595536A12003
     [Google Scholar]
  110. AokiH. KurataY. KamachiH. NakanishiH. Skin agent for external use and cosmetic agent including ubiquinone derivative or salt thereof and method using the same.Patent US201000748792007
     [Google Scholar]
  111. LiS. WangR. Shikonin, alkannin; and racemic parent nucleus cabonyl oxime derivatives and applications thereof.Patent US9630912B22013
     [Google Scholar]
  112. XunH. YanyanX. Application of naphthoquinone compounds.Patent CN101234100A2008
     [Google Scholar]
  113. ShaoshunL. RubingW. Preparation method of high optical purity shikonin and alkannin, and derivatives thereof. Patent CN102399139A2011
     [Google Scholar]
  114. YunhuiX. HongfeiZ. ZhaofangD. YingZ. Mono-carboxyl chitosan/alkannin composite nanometer particles and preparation method thereof.Patent CN110384684A2019
     [Google Scholar]
  115. YonghuaY. BaohuaJ. YanjunP. XiqunJ. JunfengZ. XiongjianX. BaiX. Alkannin nano-granule and its preparation method.Patent CN1634001A2004
     [Google Scholar]
  116. XueZ. MingX. Ngr-modified alkannin nano-micelle and preparation method and application thereof.Patent CN 113350285A2021
     [Google Scholar]
  117. JinY. JingL. Application of alkannin in preparation of medicine for treating upper and lower respiratory tract allergic disease.Patent CN 106389397A2018
     [Google Scholar]
  118. ShaoshunL. Raozhen JingY. XinL. WenZ. Betahydroxyisovalerylshikonin derivative and preparation method thereof.Patent CN101863766B2010
     [Google Scholar]
  119. IsaA.A. LixinL. GuozhengH. Process for preparing alkannin or isoalkannin.Patent CN1257877C2003
     [Google Scholar]
  120. YuangangZ. LeiY. LinZ. TingtingL. HuaW. BaishiZ. ChunjianZ. FengjianY. ZhiqiangS. Method for extracting alkannin from alkanet.Patent CN101434530A2008
     [Google Scholar]
  121. Papageorgiou VassiliosP. Acylated alkannin or shikonin derivs. -useful as dermatological, bactericidal and fungicidal medicaments.Patent DE2831786A12018
     [Google Scholar]
  122. Papageorgiou VassiliosP. Alkannin isovaleric and angelica acid ester(s) - with activity against ulcus cruris, isolated from Alkanna tinctoria root.patent DE2829744A11978
     [Google Scholar]
  123. SunQ. GongT. LiuM. RenS. YangH. ZengS. ZhaoH. ChenL. MingT. MengX. XuH. Shikonin, a naphthalene ingredient: Therapeutic actions, pharmacokinetics, toxicology, clinical trials and pharmaceutical researches.Phytomedicine20229415380510.1016/j.phymed.2021.153805 34749177
     [Google Scholar]
  124. HuangC.S. LinA.H. YangT.C. LiuK.L. ChenH.W. LiiC.K. Shikonin inhibits oxidized LDL-induced monocyte adhesion by suppressing NFκB activation via up-regulation of PI3K/Akt/Nrf2-dependent antioxidation in EA.hy926 endothelial cells.Biochem. Pharmacol.201593335236110.1016/j.bcp.2014.12.005 25541286
     [Google Scholar]
  125. SuM. HuangW. ZhuB. Acetylshikonin from Zicao prevents obesity in rats on a high-fat diet by inhibiting lipid accumulation and inducing lipolysis.PLoS One2016111e014688410.1371/journal.pone.0146884 26771185
     [Google Scholar]
  126. MarkowitschS.D. VakhrushevaO. SchuppP. AkeleY. KitanovicJ. SladeK.S. EfferthT. ThomasA. TsaurI. MagerR. HaferkampA. JuengelE. Shikonin inhibits cell growth of sunitinib-resistant renal cell carcinoma by activating the necrosome complex and inhibiting the AKT/mTOR signaling pathway.Cancers (Basel)2022145111410.3390/cancers14051114 35267423
     [Google Scholar]
  127. CaoH.H. LiuD.Y. LaiY.C. ChenY.Y. YuL.Z. ShaoM. LiuJ.S. Inhibition of the STAT3 signaling pathway contributes to the anti-melanoma activities of shikonin.Front. Pharmacol.20201174810.3389/fphar.2020.00748 32536866
     [Google Scholar]
  128. RuanZ. LiangM. ShangL. LaiM. DengX. SuX. Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-κB/STAT3 and NF-κB/CSN5 signaling pathways.Pancreatology202121363064110.1016/j.pan.2021.01.023 33707115
     [Google Scholar]
  129. SunQ. DuB. WangC. XuW. FuZ. YanY. LiS. WangZ. ZhangH. Ultrasound-assisted ionic liquid solid–liquid extraction coupled with aqueous two-phase extraction of naphthoquinone pigments in arnebia euchroma (Royle) johnst.Chromatographia201982121777178910.1007/s10337‑019‑03804‑y
     [Google Scholar]
  130. WeiQ. SuJ. DongG. ZhangM. HuoY. DongZ. Glycolysis inhibitors suppress renal interstitial fibrosis via divergent effects on fibroblasts and tubular cells.Am. J. Physiol. Renal Physiol.20193166F1162F117210.1152/ajprenal.00422.2018 30969803
     [Google Scholar]
  131. YamashitaK. MiyazakiH. ShinodaS. HagiwaraS. TakahashiH. ItagakiH. Assessment of the skin sensitizing potential of chemicals, contained in foods and/or cosmetic ingredients, using a modified local lymph node assay with an elicitation phase (LLNA:DAE) method.J. Toxicol. Sci.201843851352010.2131/jts.43.513 30078837
     [Google Scholar]
  132. SinghS. DubeyS. RanaN. Phytochemistry and pharmacological profile of drumstick tree “Moringa oleifera Lam”: An overview.Curr. Nutr. Food Sci.202319552954810.2174/1573401319666221226144613
     [Google Scholar]
  133. SinghS. SharmaK. GoswamiM. SharmaH. Phytochemical, pharmacological profile and biotechnology approaches in the production of Coriandrum sativum Linn.Curr. Org. Chem.2023271189391310.2174/1385272827666230907112523
     [Google Scholar]
  134. SinghS. AgarwalN. Study the pharmacognostic profile, antiradical and hepatoprotective potential of Carissa carandas Linn. fruit extract.Recent Adv. Food Nutr. Agric.202213212013110.2174/2212798412666220302163553
     [Google Scholar]
  135. SinghS. Evaluation of in-vitro antioxidant potential and antimicrobial activity of Nephrolepis biserrata (sw.) schott. leaf extracts.Antiinfect. Agents2022204e01052220432010.2174/2211352520666220501163415
     [Google Scholar]
  136. Akbar, S.; Akbar, S. Handbook of 200 Medicinal Plants; Springer, 2020.
/content/journals/cbc/10.2174/0115734072307327241023182640
Loading
Review on Bioactive Compound, Alkannin/Shikonin: Isolation, Biosynthesis, Formulations, Clinical Trials, Patents and Toxicity with Phytochemicals and Pharmacological Properties of an Endangered Species, Alkanna tinctoria
Curr. Bioact. Compd. 21, e15734072307327 (2025); https://doi.org/10.2174/0115734072307327241023182640
/content/journals/cbc/10.2174/0115734072307327241023182640
/content/journals/cbc/10.2174/0115734072307327241023182640
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Alkanna tinctoria; alkannin; boraginaceae; endangered species; phytochemistry; shikonin

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test